SCHEMBL1129747

SCHEMBL1129747

CCCCC(CC)C(=O)NCCc1c[nH]c2ccc(C)cc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.63
MTNR1B P49286 1/20 0.63
GFER P55789 1/20 0.56
MAPT P10636 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
POLB P06746 1/20 0.55
SPR P35270 1/20 0.55
GAA P10253 1/20 0.54
PTGS2 P35354 3/20 0.53
PTGS1 P23219 3/20 0.53
TRPV1 Q8NER1 2/20 0.52
HPGD P15428 2/20 0.52
ALDH1A1 P00352 1/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
ATM Q13315 1/20 0.50
SNCA P37840 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1130185 0.89 MTNR1A (0.68) MTNR1AMTNR1BGFERMAPTSMN1; SMN2
SCHEMBL1129797 0.88 MTNR1A (0.64) MTNR1AMTNR1BGFERSPRPTGS2
SCHEMBL1130006 0.87 MTNR1A (0.67) MTNR1AMTNR1BMAPTPOLBTRPV1
SCHEMBL2608951 0.83 SPR (0.77) MTNR1AMTNR1BGFERMAPTSMN1; SMN2
SCHEMBL11081557 0.81 MTNR1A (0.62) MTNR1AMTNR1BMAPTSPRPTGS2
SCHEMBL31036268 0.81 MTNR1A (0.72) MTNR1AMTNR1BMAPTSMN1; SMN2POLB
SCHEMBL1130207 0.79 TRPV1 (0.80) MTNR1AMTNR1BPTGS2TRPV1HPGD
SCHEMBL20648099 0.79 TRPV1 (0.80) MTNR1AMTNR1BPTGS2TRPV1HPGD
SCHEMBL17211923 0.78 MTNR1A (0.76) MTNR1AMTNR1BGFERMAPTSMN1; SMN2
SCHEMBL31543697 0.78 MTNR1A (1.00) MTNR1AMTNR1BGFERMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282735-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME Signum Biosciences, Inc. (US) 2011-02-16 EP claimed
WO-2009132051-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2009-10-29 WO claimed
US-10583119-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2020-03-10 US disclosed
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2017-09-21 US disclosed
US-9486441-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2016-11-08 US disclosed
EP-2282735-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME Signum Biosciences, Inc. (US) 2011-02-16 EP disclosed
WO-2009132051-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2009-10-29 WO disclosed
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same SIGNUM BIOSCIENCES, INC. 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same PPP2CA, PPP4C, PPP6C MTNR1A 1889/4885MTNR1B 2090/4885GFER 3500/4885
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME PPP2CA, PPP4C, PPP6C MTNR1A 1889/4885MTNR1B 2090/4885GFER 3500/4885
US-10583119-B2 Compounds, compositions and methods for making the same PPP2CA, PPP4C, PPP6C MTNR1A 1889/4885MTNR1B 2090/4885GFER 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.